Comments on: TheStreet.com Inc. Booted Off Russell Index. Adams Fault? (HEB, CTIC, OCLS, VNDA, TSCM)

By: Jim

Jim — Wed, 09 Mar 2011 21:32:00 +0000

Maybe it just took awhile for his comments on CTIC to become reality. It is now trading at $0.21.

By: Dave

Dave — Sat, 16 Jan 2010 23:29:27 +0000

Well, I don’t follow Adam F.’s writings very closely anymore, although I used to. I will say this for him, Adam F. exposed Genta (GETA.OB) for the liars they are. (Formerly its symbol was GNTA. The reason for the symbol change was that it got kicked off the NASDAQ and other developments.) Adam called that stock “to a tee”. His view was proven correct. And Genta has been one of the biggest scams in the biotech world. All it does is continually dilute shareholders by means of reverse splits, PIPE’s and deals favoring “noteholders” at the expense of shareholders. And the CEO, Warrell, is one of the noteholders! The list of his lies to shareholders is as long as your arm. Find its chart on a site that can follow it back through all its permutations, say 10 years, and you’ll be amazed and disgusted by the chart.

And what Genta does “clinically” is to run trials on failed and discarded drugs. (Although it just *might* have a ray of hope with oral Ganite, but not likely.)

Anyway, Adam did call GNTA correctly. It would have behooved shareholders to listen to him. I don’t know enough to write about his opinions about other stocks than Genta.

By: mike

mike — Sat, 16 Jan 2010 20:48:21 +0000

a.f did a number on ariad, ARIA. THANKS ALOT A.F aka duetchebag.

By: Justmeinnh2

Justmeinnh2 — Sat, 16 Jan 2010 20:06:01 +0000

Now you can add Adventrx (ANX) to that idiots (Adam Feuerstein) list…

By: R. Vangala

R. Vangala — Sat, 16 Jan 2010 14:44:25 +0000

Same with DNDN, HEB, ANX and CVM. With CVM he was thrashing the stock, while another Street.com contributor, Hal Mintz who runs BAM LLC. unloaded 10 million shares a few days before. I have complained to SEC- others state it is not going to help. But you to begin complaining to SEC until they get drowned. Retail investors at a political science major’s mercy esp. when he touts or mostly THRASHES biotech. He has survived so far because BIG BOYS in Wall Street are protecting him. This has to come to an end.

By: Susan

Susan — Sat, 16 Jan 2010 14:41:46 +0000

And CVM too!

By: pete

pete — Mon, 30 Nov 2009 00:16:39 +0000

You forgot HGSI !

By: Forde Oppenheimer

Forde Oppenheimer — Sun, 04 Oct 2009 23:50:34 +0000

The same has been taking place concerning Novavax (NVAX). The endless barrage of attacks by TheStreet.com has erroded the faith of stock holders, bashing the company as simply a swine flu stock, when in reality Novavax is anything but a one hit wonder. Novavax has a deep pipeline of drugs in human trials which consist of:

HIV (AIDS) with funding support from the National Institutes of Health. Scientific collaborators at Harvard Medical School, Emory University and the University of Alabama – Birmingham, have conducted pre-clinical testing using the vaccine.

H5N1 (Avian flu) whick has completed human phase II with +94 efficacy.

VZV (Varicella Zoster), Current vaccine provides ~50% efficacy. Government has issued a universal recommendation for all US citizens 60 years of age to be vaccinated against VZV.
Potential advantages of Novavaxâ€™s VZV vaccine:

â€¢Broad immune response
â€¢Potential safety advantages because of lack of replication
â€¢Manufacturing efficiencies: live VZV not needed for process
â€¢Vaccine is currently in discovery/preclinical development.

H1N1, passed animal trails (100% efficacy) and now in human trials with same results.

These are just few of the vaccines in Novavax’s pipeline, so why does TheStreet.com continue hounding this company, steadily trying to beat the company into bankruptcy? I have my suspicions, but will not post them without proof, something TheStreet.com should learn to do.

By: osiris

osiris — Thu, 10 Sep 2009 17:34:32 +0000

Adam Feuerstein did the same thing for OSIR. September 3 and 4 stock went down a bit before Labor day weekend. After the first dip on September 3, 2009, he posted a story entitled:

“Osiris Tanks on Data Leak?”

And made innuendos about data leaking from OSIR. Even though it later turns out OSIR didn’t get the data until market close on Sept 4, 2009 (Friday) after market close.

They mulled it over the weekend and release results when market opened on Tuesday September 8, 2009. Stock went down further.

Meanwhile Adam Feuerstein kept posting, emphasizing it was a pattern of problems.

When it turns out the trial results were a simple outcome of having more of the severe patients in the drug arm of the trial. So comparing the overall numbers was not representative. Basically OSIR did better than the placebo on all the subsets, yet did bad on the overall numbers because of this mismatch.

One analyst got the executive to reveal this during the conference call.

Some article took care to emphasize the strong response on severe patients of the drug.

But not Adam Feuersteing of course.

By: southernbeachguy1960

southernbeachguy1960 — Wed, 09 Sep 2009 20:58:52 +0000

This was passed on from another Posting service. It looks like some of these companies that have had people Slander them are not going to take it anymore. If Adam keeps it up he may have to defend himself in Court rather than on Blogs.

TORONTO, Sept. 9 /PRNewswire-FirstCall/ – The following two issuers (HTDS) http://www.htdsmedical.com and (LDSR) http://www.landstarcorp.com announced today that its investor relations firm, Mina Mar Group is offering a cash reward program designed to track down, and prosecute individuals attempting to manipulate the prices of its clients’ stocks, including HTDS, and LDSR and to expose the identity of any persons who slander or defame its clients while hiding their identity.